UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

PloS one, 2020-04, Vol.15 (4), p.e0231953

2020

Volltextzugriff (PDF)

Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

BMC cancer, 2022-04, Vol.22 (1), p.407-407, Article 407

2022

Volltextzugriff (PDF)

Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients

Journal of translational medicine, 2022-08, Vol.20 (1), p.370-370, Article 370

2022

Volltextzugriff (PDF)

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer

Cancers, 2021-09, Vol.13 (19), p.4839

2021

Volltextzugriff (PDF)

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue

BMC cancer, 2017-04, Vol.17 (1), p.241-241, Article 241

2017

Volltextzugriff (PDF)

A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies

Heliyon, 2021-03, Vol.7 (3), p.e06438-e06438, Article e06438

2021

Volltextzugriff (PDF)

Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211010156

2021

Volltextzugriff (PDF)

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort

Cancer Immunology, Immunotherapy, 2023-07, Vol.72 (7), p.2075-2086

2023

Volltextzugriff (PDF)

Analysis of Gene Expression and Ig Transcription in PU.1/Spi-B-Deficient Progenitor B Cell Lines

The Journal of immunology (1950), 2004-01, Vol.172 (1), p.144-154

2004

Volltextzugriff (PDF)

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

BMC cancer, 2016-02, Vol.16 (143), p.143-143, Article 143

2016

Volltextzugriff (PDF)

27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study

Clinical lung cancer, 2023-03, Vol.24 (2), p.137-144

2023

Volltextzugriff (PDF)

Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells

Journal of Immunology, 2006-08, Vol.177 (4), p.2195-2207

2006

Volltextzugriff (PDF)

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy

JCO precision oncology, 2022-03, Vol.6, p.e2000368

2022

Volltextzugriff (PDF)

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

BMC cancer, 2016-04, Vol.16 (276), p.275-275, Article 275

2016

Volltextzugriff (PDF)

Regulation of the Interleukin-7 Receptor α Promoter by the Ets Transcription Factors PU.1 and GA-binding Protein in Developing B Cells

The Journal of biological chemistry, 2007-05, Vol.282 (19), p.14194-14204

2007

Volltextzugriff (PDF)

Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality

Experimental hematology, 2007-07, Vol.35 (7), p.1056-1068

2007

Volltextzugriff (PDF)

Routine Screening for Triple-Negative Adenocarcinoma (TNA) Lung Cancer Patients: A New Hope for a Poor-Prognosis Population

American journal of clinical pathology, 2013-09, Vol.140 (suppl_1), p.A149-A149

2013

Volltextzugriff (PDF)

Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling

European journal of immunology, 2008-09, Vol.38 (9), p.2587-2599

2008

Volltextzugriff (PDF)

Abstract 23: Validation of a 27-gene immuno-oncology algorithm in metastatic urothelial carcinoma treated with an immune checkpoint inhibitor

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.23-23

2021

Volltextzugriff (PDF)

Abstract 175: Pathway modeling to translate the 27-gene immuno-oncology algorithm into bladder cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.175-175

2021

Volltextzugriff (PDF)

The 27-gene IO score is associated with molecular features and response to immune checkpoint inhibitors (ICI) in patients with gastric cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4058-4058

2022

Volltextzugriff (PDF)

Abstract PD10-06: Predictive value of RT-qPCR 27-gene IO score and comparison with RNA-Seq IO score in the NeoTRIPaPDL1 trial

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD10-06-PD10-06

2022

Volltextzugriff (PDF)

Abstract P2-07-12: Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-07-12

2022

Volltextzugriff (PDF)

Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3117-3117

2020

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue

A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies

Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab

An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort

Analysis of Gene Expression and Ig Transcription in PU.1/Spi-B-Deficient Progenitor B Cell Lines

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study

Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

Regulation of the Interleukin-7 Receptor α Promoter by the Ets Transcription Factors PU.1 and GA-binding Protein in Developing B Cells

Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality

Routine Screening for Triple-Negative Adenocarcinoma (TNA) Lung Cancer Patients: A New Hope for a Poor-Prognosis Population

Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling

Abstract 23: Validation of a 27-gene immuno-oncology algorithm in metastatic urothelial carcinoma treated with an immune checkpoint inhibitor

Abstract 175: Pathway modeling to translate the 27-gene immuno-oncology algorithm into bladder cancer

The 27-gene IO score is associated with molecular features and response to immune checkpoint inhibitors (ICI) in patients with gastric cancer

Abstract PD10-06: Predictive value of RT-qPCR 27-gene IO score and comparison with RNA-Seq IO score in the NeoTRIPaPDL1 trial

Abstract P2-07-12: Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial

Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer

Suchergebnisse filtern